Author： Galema-Boers J. Lenzen M. Domburg R. Roeters van Lennep J. Bruchem-van de Scheur G. Sijbrands E. Langendonk J.
Publisher： Springer Publishing Company
ISSN： 0031-6970
Source： European Journal of Clinical Pharmacology, Vol.70, Iss.4, 2014-04, pp. : 391-397
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Access to resources
Recommend
Colesevelam: In Pediatric Patients with Heterozygous Familial Hypercholesterolemia
Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. :
New therapies for familial hypercholesterolemia
By Burnett John R Watts Gerald F
Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. :
Apolipoprotein polymorphisms and familial hypercholesterolemia
Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. :
Gene Therapy for Familial Hypercholesterolemia
Current Pharmaceutical Design, Vol. 17, Iss. 24, 2011-08 ,pp. :